Trials / Completed
CompletedNCT00428649
Optimization of Selenoprotein P in Chinese Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 98 (actual)
- Sponsor
- Vanderbilt University · Academic / Other
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the amount of selenium as selenomethionine that is required to optimize selenoprotein P in selenium-deficient Chinese subjects
Detailed description
Selenium is an essential nutrient. The Recommended Dietary Allowance (RDA) for selenium is considered to be the amount required to optimize plasma selenoproteins. There are two selenoproteins present in the plasma: selenoprotein P (Se-P) and glutathione peroxidase 3 (GPX-3). Although the amount of selenium required to optimize GPX-3 has been determined, the amount required to optimize Se-P in the plasma remains unknown. We aim to determine this amount by supplementing selenium deficient subjects with varying amounts of selenium as selenomethionine. The study will take place in Mianning County, China, where selenium status is low. Approximately 150 people will be screened for eligibility to participate in this study. 98 subjects will be enrolled. Background information obtained from each participant will be: age, height, weight and smoking status. Subjects will be randomized to a selenium supplement group. The selenium supplement will contain either 0, 20, 40, 60, 80, 100, or 120 µg of selenium as selenomethionine. A CDC worker will visit each participant daily to give them their selenium supplement. The CDC worker will watch them take their supplement and will ask if they have any unanticipated problems. Blood samples of 20 ml will be obtained at weeks 0, 4, 8, 12, 16, 20, 24, 32, and 40. Hair samples and 24-hr urine collections will be obtained at 0, 20 and 40 weeks. The total study duration is 40 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 20 µg selenium | 20 µg selenium as selenomethionine |
| DIETARY_SUPPLEMENT | 40 µg selenium | 40 µg selenium as selenomethionine |
| DIETARY_SUPPLEMENT | 60 µg selenium | 60 µg selenium as selenomethionine |
| DIETARY_SUPPLEMENT | 80 µg selenium | 80 µg selenium as selenomethionine |
| DIETARY_SUPPLEMENT | 100 µg selenium | 100 µg selenium as selenomethionine |
| DIETARY_SUPPLEMENT | 120 µg selenium | 120 µg selenium as selenomethionine |
| DIETARY_SUPPLEMENT | placebo | placebo |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2007-12-01
- Completion
- 2008-10-01
- First posted
- 2007-01-30
- Last updated
- 2012-03-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00428649. Inclusion in this directory is not an endorsement.